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Background: Diet plays a major role in cardiovascular disease (CVD) risk.
Objectives: To determine the effectiveness of a Mediterranean-style diet for the primary and 
secondary prevention of CVD.
Methods: We searched for randomised controlled trials (RCTs) of Mediterranean-style diets in 
healthy adults and those at increased risk of CVD (primary prevention) and with established 
CVD (secondary prevention).
Results: Thirty RCTs were included, 22 in primary prevention and eight in secondary prevention. 
Clinical endpoints were reported in two trials where there was moderate quality evidence for 
a reduction in strokes for primary prevention, and low quality evidence for a reduction in total 
and CVD mortality in secondary prevention. We found moderate quality evidence of improve-
ment in CVD risk factors for primary prevention and low quality evidence of little or no effect 
in secondary prevention.
Conclusions: There is still some uncertainty regarding the effects of a Mediterranean-style diet 
in CVD prevention. 
Keywords: Mediterranean dietary pattern; Cardiovascular disease; Cardiovascular risk factors; 
Primary Prevention; Secondary Prevention; Systematic Review
Introduction
Cardiovascular disease (CVD) is currently the leading cause of mortality worldwide, causing one-third of 
deaths globally [1]. Preventative strategies focus on modifiable risk factors such as high blood pressure, high 
cholesterol, smoking, obesity and poor diet, which account for a large proportion of the overall CVD burden 
[1], with poor diet estimated to be responsible for the largest contribution in Europe [2].
The Seven Countries study from the 1960s demonstrated the potential beneficial effects of a Mediterranean 
dietary pattern [3]. Systematic reviews of prospective observational studies have confirmed that greater 
adherence to a Mediterranean diet is associated with a significant improvement in health status and a signif-
icant reduction in overall mortality, as well as in morbidity and mortality from CVD and other major chronic 
diseases [4–9]. Benefits have also been found for individual CVD risk factors [10, 11]. There is less evidence 
however from well-conducted and adequately powered randomised controlled trials (RCTs).
Studies also differ in their definition of a Mediterranean diet. The original description reflects the com-
mon dietary pattern of communities in countries of the Mediterranean region in the early 1960s [3], which 
was an expression of common cultural and historical roots, and a shared set of lifestyle and eating habits 
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rather than a mere assortment of specific micro- and macro-nutrients [12]. The Mediterranean diet has 
been defined [13–16], and includes the following dietary factors: a high intake of plant foods comprising 
mainly fruits and vegetables, cereals and whole-grain breads, beans, nuts and seeds; locally grown, fresh and 
seasonal, unprocessed foods; large quantities of fresh fruit consumed daily whereas concentrated sugars or 
honey are consumed a few times per week in smaller quantities; olive oil as a main cooking ingredient and 
source of fat; low to moderate amounts of cheese and yogurt; low quantities of red meat and higher quanti-
ties of fish; and low to moderate amounts of red wine often accompanying main meals.
There is evidence supporting potential mechanisms to explain the beneficial effect of the Mediterranean 
diet on cardiovascular health [17]. Favourable effects have been shown on insulin resistance and endothe-
lium-dependent vasoreactivity, as well as the antioxidant and anti-inflammatory effects of the Mediterranean 
diet and its individual components [18–23]. In addition, the Mediterranean dietary pattern has been asso-
ciated with beneficial effects on many cardiovascular risk factors, including lipoproteins, obesity, diabetes 
mellitus and hypertension [10, 11, 24–28]. The protective effects of a Mediterranean-style diet on health 
outcomes are likely derived from synergistic interactions among different components as a whole dietary 
pattern rather than from relative effects of specific food groups [5]. The objectives of this review were to 
synthesise evidence from RCTs to determine the effectiveness of advice to follow a Mediterranean-style diet 
or provision of foods relevant to a Mediterranean-style diet, or both, on clinical endpoints and cardiovascular 
risk factors for the primary and secondary prevention of CVD [29]. 
Methods 
Eligibility criteria 
We included RCTs with follow-up periods of three months or more, examining the effects of a Mediterra-
nean-style diet in adults (18 years or more) without established CVD and in those with established CVD 
to determine the effects of the intervention on primary and secondary prevention respectively. To reach 
our definition of a Mediterranean-style diet the intervention needed to include at least the following two 
components: a high monounsaturated/saturated fat ratio (use of olive oil as main cooking ingredient and/
or consumption of other traditional foods high in monounsaturated fats such as tree nuts); and high intake 
of plant-based foods, including fruits, vegetables and legumes. This definition was based on recent work 
showing that the protective effects of the diet appear to be most attributable to olive oil, fruits, vegetables 
and legumes [5, 30]. We considered trials where the comparison group was no intervention or minimal 
intervention (e.g. leaflet to follow a dietary pattern with no person-to-person intervention or reinforcement) 
and also other dietary interventions. Outcomes included CVD clinical endpoints and CVD risk factors (lipid 
levels, blood pressure).
Information sources and search strategy
We identified trials through systematic searches of the following bibliographic databases (from inception 
to 26 September 2018): Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and Web of Sci-
ence Core Collection. We adapted the preliminary search strategy for MEDLINE (Ovid) for use in the other 
databases (Appendix 1). In addition, we checked reference lists of reviews for additional studies. We searched 
ClinicalTrials.gov and the World Health Organization International Clinical Trials Registry Platform (ICTRP) 
for ongoing trials. We applied no date or language restrictions. We contacted authors where necessary for 
further information. 
Study selection
Two review authors (of KR, NM, AT, LE, DW, AV, AD) independently screened titles and abstracts for inclu-
sion of all the potential studies identified as a result of the searches and coded them as ‘retrieve’ (eligible or 
potentially eligible/unclear) or ‘do not retrieve’. We combined the responses from each of the two review 
authors and retrieved the full-text study reports/publications. Two review authors (of KR, NM, AT, LE, DW, 
AV, AD, LH) independently screened the full text and identified studies for inclusion and exclusion using the 
pre-specified inclusion criteria. In the case of any disagreements, a third author arbitrated (KR). 
Data abstraction 
We used a data collection form for study characteristics and outcome data, which we had piloted. Two review 
authors (of KR, LE, DW, AV, AD, LH) extracted study characteristics and outcome data from included stud-
ies. Disagreements were resolved by consensus or by involving a third person (KR). One review author (KR) 
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transferred data into the Review Manager software [31]. We double-checked that data were entered correctly 
by comparing the data presented in the systematic review with the data extraction form.
Assessment of risk of bias in included studies 
Two review authors (of KR, LE, DW, AV, AD, LH) independently assessed risk of bias for each study using the 
criteria outlined in the Cochrane Handbook for Systematic Reviews of Interventions [32]. We resolved any 
disagreements by discussion or by involving another author (KR). We assessed the risk of bias according to 
the following domains: random sequence generation, allocation concealment, blinding of participants and 
personnel, blinding of outcome assessment, incomplete outcome data, selective outcome reporting and 
other bias. We graded each potential source of bias as high, low or unclear. 
Measures of treatment effect 
We processed data in accordance with the Cochrane Handbook for Systematic Reviews of Interventions [32]. 
We expressed dichotomous outcomes as risk ratios (RR) with 95% confidence intervals (CI). Where available 
we used adjusted estimates of treatment effect as hazard ratios, and used the inverse variance method to 
pool these statistically. For continuous variables, we compared net changes (i.e. intervention group minus 
control group differences) and calculated mean differences (MD) and 95% CIs for each study. For trials with 
multiple arms we divided the control group N by the number of arms to avoid double-counting in meta-
analyses. We analysed outcomes at the longest period of follow-up where multiple measurements had been 
taken unless there was significant (> 30%) attrition. We narratively described skewed data reported as medi-
ans and interquartile ranges.
Data synthesis 
We summarised and analysed all eligible studies in Review Manager 5. We undertook meta-analyses only 
where this was meaningful, i.e. if the treatments, participants and the underlying clinical question were 
similar enough for pooling to make sense. We used a random-effects model as we could not assume that all 
studies in the meta-analysis are estimating the same intervention effect, but rather are estimating interven-
tion effects that follow a distribution across studies. We used the I² statistic to measure heterogeneity among 
the trials in each analysis. We used the five GRADE considerations (study limitations, consistency of effect, 
imprecision, indirectness and publication bias) to assess the quality of a body of evidence as it relates to the 
studies that contribute data to the meta-analyses for the prespecified outcomes. In the main analysis we did 
not combine primary and secondary prevention studies and different comparator groups as this would have 
made interpretation of the results difficult due to heterogeneity; instead we conducted four main analyses: 
Mediterranean dietary intervention versus no intervention or minimal intervention for primary prevention; 
Mediterranean dietary intervention versus another dietary intervention for primary prevention; Mediter-
ranean dietary intervention versus usual care for secondary prevention; Mediterranean dietary intervention 
versus another dietary intervention for secondary prevention. 
Results
Study selection and characteristics
Searching for this updated Cochrane review yielded 9483 records after duplicates were removed. Following 
screening of titles and abstracts 9296 were excluded and 187 full text papers were assessed for eligibil-
ity. Twenty one completed and seven ongoing trials were included from the new search. Six studies were 
included from the previous review and rescreening the original database identified three further trials, so a 
total of 30 completed studies and seven ongoing trials were included in this review (Figure 1). 
The characteristics of the 30 completed included studies are shown in Table 1. Results are described for 
each of the four main analyses.
1. Mediterranean dietary intervention versus no intervention or minimal intervention for 
primary prevention
Nine trials were included with 1337 participants randomised. The majority of participants were classified as 
healthy and were recruited by three of the trials [35, 41, 44], with two further trials recruiting elderly people 
[37, 39]. The remaining four trials recruited participants at increased cardiovascular risk [36, 43, 46, 61]. 
Two trials recruited only women [35, 41], and one only men [46]. The trials were conducted in the US [41], 
Italy [35, 43], Spain [44], Greece [36], Norway [46], Australia [39], and the UK [37, 61]. The duration of the 
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intervention and follow-up periods varied: three months [44, 61], six months [35, 36, 39, 41, 46], one year 
[37], and two years [43]. 
2. Mediterranean dietary intervention versus another dietary intervention for primary 
prevention 
Thirteen trials were included with 8687 participants randomised. The majority of participants were enrolled 
in one large multicentre trial with 7747 participants [51]. The majority of participants were described as 
at increased cardiovascular risk [33, 34, 40, 42, 45, 49, 50, 51, 52, 56, 57, 60]. One study recruited women 
with breast cancer [55], two trials recruited only women [34, 55]. The trials were conducted in Spain [45, 
51], Italy [40, 49, 56], Greece [33, 55], France [60], the UK [42, 57], Poland [34], Australia 52], and China 
[50]. The duration of the intervention and follow-up periods varied: three months [40, 52, 56, 60], four 
months [33, 34], six months [49, 55], one year [42, 50, 57], two years [45], and up to five years [51]. The 
dietary interventions in the comparison group varied, including low-fat [33, 42, 45, 50, 51, 52, 57, 60], the 
traditional diet of that country [34], national recommendations/disease-specific guidance [49, 55], and 
vegetarian [40, 56].
Figure 1: PRISMA flow for study selection.
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3. Mediterranean dietary intervention versus usual care for secondary prevention 
Two trials were included with 706 participants randomised. Both trials recruited patients with CVD, one in 
men and women with CHD [48], and the other in men and women who had experienced a myocardial infarc-
tion within six months [58]. Participants were recruited from Germany [48], and France [58]. The duration of 
the intervention and follow-up periods varied from 12 months to 24 and 46 months [48, 58].
4. Mediterranean dietary intervention versus another dietary intervention for secondary 
prevention 
Six trials were included with 1731 participants randomised. An expression of concern has been published 
about the reliability of two of the studies in this comparison group with the majority of participants [53, 
54, 63, 64], and we have conducted sensitivity analyses excluding these studies from all analyses. All tri-
als recruited patients with CVD. Three trials recruited men and women with CHD [38, 47, 62], one after a 
first myocardial infarction [59] and one with acute myocardial infarction or unstable angina [53]. One trial 
recruited patients with established CHD or those at high risk of CHD, although the majority of participants 
had established disease [54]. Participants were recruited from Australia [38, 47], the US [59], Brazil [62], 
and India [53, 54]. The duration of the intervention and follow-up periods varied: three months [38, 62], six 
months [47], and two years [53, 54, 59]. The dietary interventions in the comparison group varied, including 
low-fat [38, 47, 59], and national recommendations/disease-specific guidance [53, 54, 62].
Risk of bias in included studies 
The risk of bias of included studies is shown in Figure 2. The blinding of participants and personnel for 
behavioural interventions is difficult, if not impossible, in most cases and so we have not judged this as a 
high risk of bias. We rated this domain as unclear for all trials in all four comparison groups.
1. Mediterranean dietary intervention versus no intervention or minimal intervention for 
primary prevention
The methods of random sequence generation were unclear in six of the nine included studies [35, 36, 37, 41, 
46, 61], and we judged the methods used to be at low risk of bias in the remaining three [39, 43, 44]. The 
methods of allocation concealment were unclear in seven studies and at low risk of bias in the remaining 
two [43, 61]. Blinding of outcome assessment was unclear in eight trials, in the remaining trial we judged 
this to be at low risk of bias [43]. We judged three trials to be at low risk of attrition bias [43, 44, 61], one 
study was at high risk of bias as there was differential loss to follow-up [41], and the remaining trials were 
judged as unclear. The risk of bias associated with selective reporting was judged as low risk in five trials [39, 
41, 43, 44, 61], and unclear in the remaining four. There was insufficient information to judge the risk of 
other sources of bias and we categorised all nine studies as unclear. 
2. Mediterranean dietary intervention versus another dietary intervention for primary 
prevention  
The methods of random sequence generation were unclear in six of the 13 included studies [33, 45, 40, 52, 
55, 60], and judged at low risk of bias in the remaining seven [34, 42, 49, 50, 51, 56, 57]. The methods of 
allocation concealment were unclear in 10 studies and at low risk of bias in the remaining three [42, 56, 
57]. Blinding of outcome assessment was unclear in 10 of the 13 trials and judged at low risk of bias in the 
remaining three [34, 49, 56]. We judged six of the 13 trials to be at low risk of attrition bias [33, 34, 42, 49, 
51, 56], one study to be at high risk of bias for attrition due to differential loss to follow-up [60], and unclear 
in the remaining six trials. The risk of bias associated with selective reporting was unclear in four studies and 
judged to be of low risk of bias for the remaining nine [33, 34, 42, 49, 50, 51, 55, 56, 60]. There was insuf-
ficient information to judge the risk of other sources of bias and we categorised all 13 studies as unclear.
3. Mediterranean dietary intervention versus usual care for secondary prevention  
The methods of random sequence generation were unclear in one of the two included studies [58], and in 
the other we judged the methods used to be at low risk of bias [48]. The methods of allocation concealment 
were unclear in one study [48], and at low risk of bias in the other [58]. Blinding of outcome assessment was 
unclear in one trial at low risk of bias for the other [48, 58]. We judged both trials to be at low risk of attrition 
bias and selective reporting. There was insufficient information to judge the risk of other sources of bias and 
we categorised both studies as unclear.
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4. Mediterranean dietary intervention versus another dietary intervention for secondary 
prevention  
The methods of random sequence generation were unclear in five of the six included studies [38, 53, 54, 59, 
62], and in the one study where this was clear, we judged the methods used to be at low risk of bias [47]. 
The methods of allocation concealment were unclear in four studies and at low risk of bias in the remaining 
two [59, 62]. Blinding of outcome assessment was unclear in five studies and judged to be at low risk of bias 
in one [54]. The risk of attrition bias was unclear in all six trials. The risk of bias associated with selective 
reporting was unclear in three studies and at low risk of bias in three [54, 59, 62]. An expression of concern 
Figure 2: Risk of bias assessment of included studies.
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has been published about the reliability of two of the studies in this comparison group [53, 54, 63, 64]. We 
have conducted sensitivity analyses excluding these studies from all analyses. We regarded these two studies 
as at high risk of other bias. We judged the remaining four studies as at unclear risk of other sources of bias 
as there was insufficient information to make a judgement.
Effects of interventions 
CVD clinical events
We assessed the overall quality of evidence using the five GRADE considerations (study limitations, consist-




None of the nine included studies reported on clinical events. 
2. Mediterranean dietary intervention versus another dietary intervention for primary 
prevention   
The PREDIMED trial was the only trial reporting clinical events for this comparison [51]. This trial was 
retracted and re-analysed following concerns regarding randomisation at two of 11 sites and the inclusion of 
non-randomised second household members. Low-quality evidence shows little or no effect of the interven-
tion (advice to follow a Mediterranean diet plus supplemental extra-virgin olive oil or tree nuts) compared 
to a low-fat diet on CVD mortality (hazard ratio [HR] 0.81, 95% confidence interval [CI] 0.50 to 1.32) or total 
mortality (HR 1.0, 95% CI 0.81 to 1.24) over 4.8 years. There was, however, a reduction in the number of 
strokes with the intervention (HR 0.60, 95% CI 0.45 to 0.80), moderate-quality evidence).
3. Mediterranean dietary intervention versus usual care for secondary prevention   
The Lyon Diet Heart Study examined the effect of advice to follow a Mediterranean diet and supplemental 
canola margarine compared to usual care in 605 CHD patients over 46 months and there was low-quality 
evidence of a reduction in adjusted estimates for CVD mortality (HR 0.35, 95% CI 0.15 to 0.82) and total 
mortality (HR 0.44, 95% CI 0.21 to 0.92) with the intervention [58]. 
4. Mediterranean dietary intervention versus another dietary intervention for secondary 
prevention  
Three studies reported clinical endpoints for this comparison group [53, 54, 59], and two of these were 
excluded in sensitivity analyses from all main analyses due to published concerns regarding the reliability of 
the data [53, 54, 63, 64]. Only one small trial (101 participants) provided unadjusted estimates for composite 
clinical endpoints for comparison four (very low-quality evidence of uncertain effect) [59]. 
Cardiovascular risk factors
We assessed the overall quality of evidence using the five GRADE considerations (study limitations, consist-
ency of effect, imprecision, indirectness and publication bias) presented in Table 3 for each of the four 
main comparisons. Figures 3–8 show stacked forest plots for the four main comparisons for each of the 
following outcomes: Total cholesterol (Figure 3), LDL cholesterol (Figure 4), HDL Cholesterol (Figure 5), 
Triglycerides (Figure 6), Systolic Blood Pressure (Figure 7), Diastolic Blood Pressure (Figure 8).
1. Mediterranean dietary intervention versus no intervention or minimal intervention for 
primary prevention
For CVD risk factors for comparison one, there was low-quality evidence for a possible small reduction in 
total cholesterol (–0.16 mmol/L, 95% CI –0.32 to 0.00) and moderate-quality evidence for a reduction in 
systolic (–2.99 mmHg (95% CI –3.45 to –2.53) and diastolic blood pressure (–2.0 mmHg, 95% CI –2.29 to 
–1.71), with low or very low-quality evidence of little or no effect on LDL or HDL cholesterol or triglycerides. 
2. Mediterranean dietary intervention versus another dietary intervention for primary prevention    
For comparison 2 there was moderate-quality evidence of a possible small reduction in LDL cholesterol 
(–0.15 mmol/L, 95% CI –0.27 to –0.02) and triglycerides (–0.09 mmol/L, 95% CI –0.16 to -0.01) with mod-
erate or low-quality evidence of little or no effect on total or HDL cholesterol or blood pressure.
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Figure 3: Total Cholesterol.
Figure 4: LDL Cholesterol.
3. Mediterranean dietary intervention versus usual care for secondary prevention    
For comparison three there was low-quality evidence of little or no effect of a Mediterranean-style diet on 
lipid levels and very low-quality evidence for blood pressure. 
4. Mediterranean dietary intervention versus another dietary intervention for secondary prevention  
For comparison four where only two trials contributed to the analyses there was low or very low-quality 
evidence of little or no effect of the intervention on lipid levels or blood pressure.
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Figure 5: HDL Cholesterol.
Figure 6: Triglycerides.
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Figure 7: Systolic Blood Pressure.
Figure 8: Diastolic Blood Pressure.
Discussion
Summary of main results
In this substantive review update, 30 RCTs (49 papers) and seven ongoing trials met our inclusion crite-
ria. Four pre-specified comparison groups were used to analyse the data to address both heterogeneity 
between participants and comparison groups and aid interpretation of findings. Clinical endpoints were 
measured in only one large primary prevention trial (PREDIMED) [51], where following retraction and 
reanalysis of the data due to methodological concerns, there was low quality evidence of little or no 
effect of the intervention on total or CVD mortality or myocardial infarction but moderate quality evi-
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dence of a reduction in the number of strokes. For secondary prevention, in the Lyon Diet Heart Study 
[58], there was low quality evidence of reductions in total and CVD mortality and myocardial infarction. 
Two secondary prevention trials reporting clinical events were excluded from the main analyses due to 
published concerns regarding the reliability of the data [53, 54, 63, 64]. A further small trial reported 
unadjusted estimates for total cardiac endpoints, with very low-quality evidence showing considerable 
uncertainly of the effect size. Cardiovascular risk factors including lipid levels and blood pressure were 
reported in all four comparison groups, with most of the studies contributing to primary prevention. 
Compared to no intervention or a minimal intervention, there was low-quality evidence for a possible 
small reduction in total cholesterol and moderate-quality evidence for a reduction in both systolic and 
diastolic blood pressure with a Mediterranean-style diet, with low or very low-quality evidence of little 
or no effect of the intervention on LDL or HDL cholesterol or triglycerides. Compared with other diets 
in primary prevention, there was moderate-quality evidence of a possible small reduction in LDL choles-
terol and triglycerides with moderate or low-quality evidence of little or no effect of the intervention on 
total or HDL cholesterol or blood pressure. In secondary prevention few trials contributed to the analyses 
with low or very low-quality evidence of little or no effect of a Mediterranean-style diet on lipid levels or 
blood pressure. 
Study limitations and strengths
There were a large number of included trials (30 trials, 12,461 participants randomised), but few reported on 
clinical endpoints, our primary outcome, and the majority of trials reported on CVD risk factors for primary 
prevention. Due to the breadth of the review question, heterogeneity in terms of participants, interven-
tions and comparators was high and we have attempted to reduce this by conducting the main analyses in 
four comparison groups for primary and secondary prevention and different comparators. Two studies were 
excluded from all main analyses in sensitivity analyses due to published concerns regarding the reliability 
of the data [53, 54, 63, 64]. Only one trial reported clinical endpoints for primary prevention and this study 
experienced methodological issues regarding randomisation with the report subsequently being retracted 
and re-analysed [51]. The findings in secondary prevention are based on one older trial reporting very large 
effect estimates using a modified Zelen design [58]. Overall most trials were at unclear risk of bias for most 
domains and so results should be treated with caution. 
We conducted a comprehensive search across major databases for interventions involving the 
Mediterranean diet. Two review authors independently selected and assessed trials for inclusion using pre-
specified criteria, extracted data and assessed the quality of trials to minimise potential biases in the review 
processes. Our decision to restrict this review to interventions that only focused on the effectiveness of a 
Mediterranean-style diet per se avoided the potential confounding effects of other behavioural interven-
tions on our outcomes, for example, those involving increased exercise in the context of trials examining 
multifactorial interventions. Our decision to exclude trials in people with diabetes who are at increased 
risk of CVD also missed relevant studies, but people with diabetes represent a distinct group and interven-
tions for the management of diabetes are covered by another review group, the Cochrane Metabolic and 
Endocrine Disorders Group.
Definitions of the Mediterranean diet differed across studies. We used a classification system in our defi-
nition in an attempt to address the heterogeneity. The components required to meet our definition of a 
Mediterranean-style diet were based on previous definitions [13–17], and required at least the following 
two core components: high monounsaturated/saturated fat ratio (use of olive oil as main cooking ingredi-
ent and/or consumption of other traditional foods high in monounsaturated fats such as tree nuts) and 
high intake of plant-based foods, including fruits, vegetables and legumes. The rationale for this definition 
is based on recent work [5, 30], which emphasises that the protective effects of the diet appear to be most 
attributable to olive oil, fruits, vegetables and legumes.
Comparison with similar studies
Several recent systematic reviews and overviews of reviews have reported on the effects of the Mediterra-
nean diet on cardiovascular health. A recent narrative overview of both prospective observational studies 
and RCTs concluded that the Mediterranean diet has some beneficial effects for CVD prevention but the 
effects were inconsistent between studies with few studies reported in meta-analyses and the overview 
authors called for more high-quality trials to address the inconsistencies [65]. This is in line with the findings 
of the current review reporting on RCT evidence. An umbrella review of systematic reviews reported on 13 
meta-analyses of observational studies and 16 meta-analyses of RCTs investigating the association between 
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the adherence to the Mediterranean diet and a number of different health outcomes [4]. The authors found 
robust evidence for a greater adherence to the Mediterranean diet and a reduced risk of overall mortality, 
cardiovascular diseases, coronary heart disease, myocardial infarction and diabetes with no evidence for LDL 
cholesterol levels. 
A recent systematic review included both primary and secondary prevention trials and pooled clinical 
endpoints for these showing beneficial effects for major vascular events (risk ratio (RR) 0.69, 95% CI 0.55 
to 0.86) and stroke (RR 0.66, 95% CI 0.48 to 0.92) [66]. A systematic review comparing the effects of a 
Mediterranean diet with low-fat diets on CVD risk factors in those at high risk or with established disease 
found favourable but modest effects of the Mediterranean diet on a wide range of cardiovascular risk fac-
tors and inflammatory markers, such as body weight, systolic and diastolic blood pressure, fasting plasma 
glucose, total cholesterol and high-sensitivity C-reactive protein [67]. Other systematic reviews have pooled 
together the evidence from both observational studies and RCTs on the effects of the Mediterranean dietary 
pattern on metabolic syndrome and individual cardiovascular risk factors, supporting favourable effects of 
the Mediterranean diet on cardio-metabolic risk factors [10, 11]. The results of the current review including 
only RCTs show inconsistencies between studies but where meta-analyses were possible there were small 
beneficial effects on some CVD risk factors for primary prevention.
Conclusions 
Despite the large number of trials included in the review there is still uncertainty regarding the effects 
of a Mediterranean-style diet on clinical endpoints and cardiovascular disease (CVD) risk factors for both 
primary and secondary prevention from current clinical trial evidence. Two trials reporting clinical end-
points for secondary prevention were excluded because of concerns regarding the reliability of the data, 
so the available evidence is restricted to one large trial and a small trial reporting unadjusted estimates 
of effect. Evidence for primary prevention on clinical endpoints is limited to one large trial with meth-
odological issues (although these have now been addressed in a recent re-analysis). Further adequately 
powered primary prevention trials are needed to confirm findings on clinical endpoints to date. Many 
trials reported on CVD risk factors, particularly in primary prevention, but heterogeneity precluded meta-
analyses for some outcomes. Several ongoing trials have been identified which will add to the evidence 
base.
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